Victory Capital Management
PBYI icon

Victory Capital Management’s Puma Biotechnology PBYI Stock Holding History

Victory Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-35,097
Closed -$89.5K – 2522
2024
Q3 		$89.5K Buy
35,097
+18,532
+112% +$56.1K ﹤0.01% 2339
2024
Q2 		$54K Buy
+16,565
New +$72.7K ﹤0.01% 2357
2020
Q2 		– Sell
-5,651
Closed -$48K – 3047
2020
Q1 		$48K Buy
+5,651
New +$54.9K ﹤0.01% 2533
2019
Q4 		– Sell
-5,770
Closed -$62K – 3076
2019
Q3 		$62K Buy
+5,770
New +$62.3K ﹤0.01% 2590

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Victory Capital Management's PBYI Position: Q4 2024 in Review

Victory Capital Management sold out of Puma Biotechnology (PBYI) in Q4 2024, closing a stake of 35,097 shares — an estimated $89.5K sold.

Victory Capital Management first reported a position in PBYI in Q3 2019 and held it in 4 quarters. The position peaked at $89.5K in Q3 2024. 112 funds tracked by Wall St. Rank hold PBYI as of Q4 2024.

  • Victory Capital Management reported no remaining Puma Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Victory Capital Management sold 35,097 Puma Biotechnology shares in Q4 2024, an estimated $89.5K.
  • Victory Capital Management first reported a position in Puma Biotechnology in Q3 2019 and held it in 4 quarters.
  • Victory Capital Management's Puma Biotechnology position peaked at $89.5K in Q3 2024.
  • 112 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2024.

Based on Victory Capital Management's 13F filing for Q4 2024, filed 6 Feb 2025.